复发非小细胞肺癌老年患者的治疗选择模式和预后因素:一项观察性研究
Dai Sonoda1, Raito Maruyama1, Yasuto Kondo1,2
1Department of Thoracic Surgery, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-Ku, Sagamihara, Kanagawa, 252-0374, Japan.
Surgery today
|September 27, 2024
概括
肺癌复发的老年患者经常拒绝积极治疗,影响结果. 积极的治疗可以改善复发的老年肺癌患者的生存率.
科学领域:
- 在瘤学瘤学.
- 老年病的医生 老年病的医生
- 公共卫生 公共卫生
背景情况:
- 全球人口老龄化,导致老年人肺癌发病率增加.
- 对于复发性肺癌的老年患者,治疗策略和生存率尚不清楚.
研究的目的:
- 以回顾性分析老年患者的治疗模式和预后,诊断出患有复发性非小细胞肺癌.
- 为了确定影响老年患者在肺癌复发后生存的因素.
主要方法:
- 对1100名为非小细胞肺癌 (2004-2017年) 进行了完全切除的患者进行了回顾性审查.
- 75岁及以上的患者被归类为"老年患者",以检查他们的预后和复发时的预后因素.
主要成果:
- 在290名复发患者中,106人是老年患者.
- 复发后的生存时间与性别,复发时间,复发次数,表现状况和积极治疗有关.
- 复发时的年龄增加与较高的不治疗率相关,这通常是由于患者/家庭的偏好.
结论:
- 患有复发性肺癌的老年患者中有很大一部分选择不接受积极治疗.
- 复发性肺癌的老年患者的预后可以通过积极的治疗干预措施来提高.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
223
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.0K
相关概念视频
Cancer Survival Analysis
329
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
329
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
